Employees: 3,611
Size Shenzhen Sunnypol Optoelectornics (002876.SZ) is a China Health Care company (Medical Specialties) with a market value of $728M, the 2982nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥28.41 on 6 Nov 2026.
Performance Over six months the shares fell 8.1%, against -8.7% for the median peer and -16.4% for the China market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 29.4% over the last twelve months (peer median +5.9%); the operating margin is 4.6% (peer median 13.7%).
Valuation It trades at 41.8× forward earnings against a peer median of 19.5× (3rd most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -3 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.4 points below its cost of capital (8.8% WACC).
Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥4.35B | CN¥3.68B | CN¥2.58B | CN¥2.06B | CN¥2.17B |
| Revenue growth | — | +43% | +25% | -5% | — |
| Gross profit | CN¥922M | CN¥540M | CN¥418M | CN¥283M | CN¥450M |
| EBITDA | n/a | CN¥376M | CN¥261M | CN¥165M | CN¥344M |
| Net income | CN¥122M | CN¥47.1M | CN¥68.1M | CN¥42.8M | CN¥206M |
| Free cash flow | CN¥346M | -CN¥157M | -CN¥438M | -CN¥630M | CN¥164M |
| Capital expenditure | CN¥144M | CN¥350M | CN¥481M | CN¥679M | CN¥252M |
| Total debt | CN¥2.58B | CN¥2.59B | CN¥1.82B | CN¥1.24B | CN¥965M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002876.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -5.8% | +0.5% | 5th lowest of 21 |
| 6-month return | -8.1% | -8.7% | 11th highest of 21 |
| Distance from 52-week high | -20.1% | -24.9% | 11th highest of 21 |
| Revenue growth (TTM) | +29.4% | +5.9% | 6th highest of 21 |
| Operating margin | 4.6% | 13.7% | 7th lowest of 21 |
| Forward P/E | 41.8× | 19.5× | 3rd most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 11.1% | 0.1% | 6th most demanding of 15 |
| Growth delivered (Del g) | +14.2% | +12.8% | 6th highest of 15 |
| Hurdle (Req g minus delivered) | -3.1 pp | -10.9 pp | 6th most demanding of 15 |
| ROIC minus cost of capital | -2.4 pp | +3.9 pp | 7th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $728M | -8% | +29% | 5% | 41.8× | 11.1% | +14.2% |
| QuidelOrtho QDEL | United States | $734M | -1% | -5% | -2% | 12.0× | n/a | n/a |
| SWS Hemodialysis Care 688410.SS | China | $723M | -12% | +31% | 19% | 24.1× | 16.7% | +25.9% |
| Mesa Laboratories MLAB | United States | $718M | +23% | +3% | 9% | 12.6× | 21.1% | +13.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $741M | -5% | +12% | 18% | 16.1× | -2.1% | +11.8% |
| Synektik SNT.WA | Poland | $713M | +16% | +50% | 24% | 11.8× | 0.1% | +40.3% |
| Shenzhen Lifotronic Technology 688389.SS | China | $749M | -11% | +14% | 13% | 32.4× | 13.5% | +13.3% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $750M | +177% | -14% | 3% | n/a | 33.5% | -0.6% |
| Livsmed 491000.KS | South Korea | $706M | -47% | +89% | -59% | n/a | n/a | n/a |
| Doctorglasses Chain 300622.SZ | China | $757M | -10% | +6% | 14% | 24.5× | -2.4% | +15.7% |
| Pacific Biosciences of California PACB | United States | $701M | +60% | +2% | -102% | n/a | n/a | n/a |
| Cytek Biosciences CTKB | United States | $758M | +26% | +5% | -22% | n/a | n/a | n/a |
| Shanghai Sanyou Medical 688085.SS | China | $700M | -21% | +15% | 4% | 50.9× | 29.1% | +6.8% |
| Shanghai Kinetic Medical 300326.SZ | China | $698M | -7% | -28% | 17% | 27.4× | 8.1% | -1.9% |
| InMode INMD | United States | $767M | -5% | -7% | 18% | 10.1× | -10.5% | +12.4% |
| Japan Lifeline 7575.T | Japan | $685M | +16% | +6% | 19% | 14.1× | -9.7% | +2.9% |
| Beijing Chunlizhengda Medical Instruments 688236.SS | China | $684M | -21% | -13% | 31% | 19.1× | -5.4% | +2.2% |
| Jiangsu Hanvo Safety Product 300952.SZ | China | $681M | -21% | +6% | 8% | 47.6× | n/a | n/a |
| BMC Medical 301367.SZ | China | $780M | -13% | +37% | 17% | 19.8× | 0.1% | +15.6% |
| Varex Imaging VREX | United States | $783M | -10% | +5% | 8% | 20.3× | n/a | n/a |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $784M | -25% | +35% | 21% | 17.8× | -2.1% | +23.5% |